Citation Impact

1 by Nobel laureates 5 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Age-Related Macular Degeneration
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
4 intermediate papers

Works of Peter Sallstig being referenced

Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
2017
OSPREY trial: randomized, active-controlled, phase II study to evaluate safety and efficacy of RTH258, a humanized single-chain anti-VEGF antibody fragment, in patients with neovascular AMD
2015

Author Peers

Author Rheumatology Nephrology Pharmacology Molecular Biology Last Decade Papers Cites
Peter Sallstig 245 364 53 302 15 742
Jochen Kade 19 48
Zachary W. Davis 12 12 197
Grinell Smith 7 5 10 15 389
Linda Titus‐Ernstoff 5 46 175 14 792
Harish Chandra Andola 82 76 23 256

All Works

Loading papers...

Rankless by CCL
2026